Spero Therapeutics (SPRO) Current Leases (2019 - 2025)
Historic Current Leases for Spero Therapeutics (SPRO) over the last 7 years, with Q3 2025 value amounting to $1.9 million.
- Spero Therapeutics' Current Leases rose 920.07% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 920.07%. This contributed to the annual value of $1.7 million for FY2024, which is 162.98% up from last year.
- According to the latest figures from Q3 2025, Spero Therapeutics' Current Leases is $1.9 million, which was up 920.07% from $1.8 million recorded in Q2 2025.
- Spero Therapeutics' 5-year Current Leases high stood at $1.9 million for Q3 2025, and its period low was $980000.0 during Q1 2021.
- Its 5-year average for Current Leases is $1.6 million, with a median of $1.7 million in 2023.
- In the last 5 years, Spero Therapeutics' Current Leases crashed by 3171.69% in 2021 and then skyrocketed by 6151.63% in 2022.
- Spero Therapeutics' Current Leases (Quarter) stood at $1.4 million in 2021, then rose by 24.08% to $1.7 million in 2022, then rose by 1.66% to $1.7 million in 2023, then rose by 1.63% to $1.7 million in 2024, then increased by 8.76% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, $1.8 million for Q2 2025, and $1.8 million during Q1 2025.